Chronic Obstructive Plumonary Disease Copd clinical trials

Explore recruiting chronic obstructive plumonary disease copd clinical trials.

Also recruiting in Europe

Chronic Obstructive Plumonary Disease Copd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A single group treatment, phase 4, study to assess the effect of 1 dose with oxymetazoline nasal spray(Otrivin®) on physical capacity of males and females aged 18 and 64 years suffering from Chronic Obstructive Pulmonary Disease (COPD)

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Obstructive Plumonary Disease Copd trials by city

Chronic Obstructive Plumonary Disease Copd in Toronto Chronic Obstructive Plumonary Disease Copd in Vancouver Chronic Obstructive Plumonary Disease Copd in Montreal Chronic Obstructive Plumonary Disease Copd in Calgary Chronic Obstructive Plumonary Disease Copd in Edmonton Chronic Obstructive Plumonary Disease Copd in Ottawa Chronic Obstructive Plumonary Disease Copd in Winnipeg Chronic Obstructive Plumonary Disease Copd in Quebec City Chronic Obstructive Plumonary Disease Copd in Hamilton Chronic Obstructive Plumonary Disease Copd in Kitchener Chronic Obstructive Plumonary Disease Copd in London Chronic Obstructive Plumonary Disease Copd in Halifax Chronic Obstructive Plumonary Disease Copd in New York Chronic Obstructive Plumonary Disease Copd in Los Angeles Chronic Obstructive Plumonary Disease Copd in Chicago Chronic Obstructive Plumonary Disease Copd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease